跳至主要内容
临床试验/NCT02956564
NCT02956564Unknown不适用

Precision Medical Research of Non-immune Fetal Hydrops (NIFH)-From Prenatal Diagnosis to Intrauterine Treatment

Shanghai First Maternity and Infant Hospital0 个研究点目标入组 144 人开始时间: 2016年12月最近更新:
适应症

试验速览

阶段
不适用
入组人数
144
主要终点
Neonatal mortality

研究概览

简要总结

Based on multi-center clinical research resources, a large-scale prospective cohort study will be conduted to make a more accurate diagnosis and intervention plan of Non-immune fetal hydrops (NIFH), and then establish NIFH accurate treatment strategy which is suitable for China's national conditions.

详细描述

  1. Etiological study of Non-immune fetal hydrops(NIFH):

  2. Etiological study of NIFH in mid-pregnancy period;

  3. Etiological study of NIFH and hygroma colli in first trimester;

  4. Value assessment of technology for exome sequencing in diagnosis of NIFH;

  5. The accuracy of NIFH intrauterine intervention and its effect assessment:

  6. Perinatal outcomes of NIFH ;

  7. The effect of intrauterine treatments.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Cases corresponding to diagnosis standards
  • Willing to accept the regular follow-up

排除标准

  • Immune hydrops fetalis
  • Multiple pregnancy, except for twin-to-twin transfusion syndrome IV

结局指标

主要结局

Neonatal mortality

时间窗: 1 year

次要结局

  • Success rate for the operation(1 week)

研究者

申办方类型
Other
责任方
Sponsor

相似试验